Skip to main content
. 2022 Jun 13;14(6):1253. doi: 10.3390/pharmaceutics14061253

Figure 1.

Figure 1

Schematic drawing of (a) self-assembled GE NPs with different HA addition forming cationic/ionic surface, and (b) two methods (eyedrops and subconjunctival injection) which were used to evaluate delivery of nanoparticles to the posterior eye segment. (Route 1: trans-corneal route, Route 2: non-corneal route).